Skip to main content
. 2024 Nov;76(6):1254–1290. doi: 10.1124/pharmrev.123.001111

Fig. 2.

Fig. 2

α-Synuclein structure with posttranslational modification sites. Created with BioRender.com pursuant to its Academic License Terms.

HHS Vulnerability Disclosure